Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422810 · ClinicalTrials.gov registry record
High-Shear Microfluidic Thrombosis Assay
A clinical trial of Coagulation Defects, Other and Unspecified, sponsored by Emory University.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT02422810: Completed study of Coagulation Defects, Other and Unspecified, sponsored by Emory University.
NCT02422810 is a study of Coagulation Defects, Other and Unspecified that has completed, run by Emory University. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422810, a study of Coagulation Defects, Other and Unspecified, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize a new test to assess the rate and time it takes to form a blood clot in people who either do or do not take aspirin.
Primary Outcome
A microfluidic assay will be used to assess thrombus formation induced by exposed collagen within a stenosis that induces high shear rates. The amount of time taken to completely occlude an aperture is called the thrombotic occlusion time.
Conditions Studied
Study Locations (1)
Georgia
- Emory Clinic - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-10 |
What the finished NCT02422810 record still lists
NCT02422810 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 1 condition, with Coagulation Defects, Other and Unspecified appearing as the primary indexed condition, and to 0 interventions.
NCT02422810 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02422810 about?
NCT02422810 is a clinical study titled "High-Shear Microfluidic Thrombosis Assay". The purpose of this study is to characterize a new test to assess the rate and time it takes to form a blood clot in people who either do or do not take aspirin.
What is the current status of trial NCT02422810?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2015-05. Estimated completion is 2015-10.
What conditions does trial NCT02422810 study?
This clinical trial studies the following conditions: Coagulation Defects, Other and Unspecified.
Who is sponsoring clinical trial NCT02422810?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02422810 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia